Essential resources, easily available.

Our e-learning modules, resources and forums provide oncology pharmacy staff with the tools required to stay abreast of the latest developments to improve patient care.

eLearning

  • Field-specific online modules
  • Supporting certification that can be used to support CPD
  • Keep up to date within the field of oncology pharmacy
  • Stop and continue the course at a time that suits you
Explore eLearning

Your community

  • Innovation through collaboration
  • Communicate with other members of the oncology pharmacy network
  • Share documents and links
  • Submit posts quickly and easily on our interactive forums
Explore community

Resources

  • Access to BOPA publications and position statements
  • Links for further reading and information
  • Checked and verified documents ensures material is current
  • Quick downloads
Explore resources

Latest news

By BOPA on 20th May 2024

ISOPP Global Drug Shortages Webinar – 29th May

  Join ISOPP’s next Global Webinar entitled “Understanding Oncology Drug Shortages from an International Perspective” taking place virtually on Wednesday, May 29 at 13:00 BST (05:00 PDT (UTC-7)) in collaboration…

Read article
By BOPA on 20th May 2024

Canada Blog: CAPhO 2024, Moncton

CAPhO 2024 Moncton – A trip across the Pond, an incredible Canadian welcome, sharing of knowledge, the freshest sea food and a East Coast Kitchen Party!   It’s not every…

Read article
By BOPA Committee on 20th May 2024

Kite and Gilead UK&I 2024 CAR-T Fellowship and Medical Grants Programme now open

Kite and Gilead UK & Ireland CAR-T Fellowship and Medical Grants Programme The Kite and Gilead UK and Ireland Fellowship and Medical Grants Programme (GFP) is a medical grants funding…

Read article
By BOPA Committee on 16th May 2024

CRUK Consent Forms – NET and Prostate Cancer Update

The regimen specific consent forms for neuroendocrine and adrenal cancers have been reviewed, updated and added to the CRUK website. In addition, a new consent form for prostate has been…

Read article
Further news